John Martin

Silihepatic

Hepatoprotective agent.

Silihepatic is a hepatoprotective agent with a modern, effective combination of active ingredients that helps restore liver function. It contains silybin (the main bioactive component of silymarin), which exerts an antioxidant action by scavenging free radicals. It also protects hepatocytes against inflammation and cytotoxicity, and supports liver detoxification mechanisms by increasing glutathione levels.

Silihepatic
TARGET SPECIES
Dogs and cats.
DOSAGE FORM
Flavoured, double-scored tablets.
HOW SUPPLIED
Box containing 30 tablets.
DIFFERENTIATORS

BENEFITS AND COMPETITIVE ADVANTAGES

Contains silybin, with bioavailability up to 10 times higher than silymarin.
Inhibits oxidative damage.
Flavoured tablets.

Inhibits oxidative damage.

Contains silybin, with bioavailability up to 10 times higher than silymarin.

• Promueve el metabolismo de las grasas.
• Reduce los niveles de lípidos en sangre y en el hígado.

Inhibits oxidative damage.

• Estimula la síntesis de proteínas en el hígado.
• Comprimidos saborizados.

Flavoured tablets.

TECHNICAL DETAILS

Information

– Silybin phospholipid complex* 70 mg; SAMe (S-Adenosyl-L-Methionine disulfate tosylate) 50 mg.
– DL-Methionine 150 mg; L(+)-Choline bitartrate 10 mg.
– Vitamin E acetate 5 mg.
– Excipients q.s. to 1000 mg.
*Equivalent to 21 mg of silybin per tablet.
The flavoured tablets are administered orally, preferably on an empty stomach and at least 1 hour before feeding.
Dogs: 1 tablet per 10 kg/day (recommended dose).
Cats: 2-5 kg: ¼ tablet/day. 5 kg or more: ½ tablet/day.
The dose may be adjusted for individual cases if necessary, at the discretion of the attending veterinarian. Note that an excessive increase in the amount of methionine administered may result in urinary acidification. Treatment duration should be at least 10 days. For prolonged use, the amount administered may be reduced by half as a maintenance dose.

Silihepatic

TARGET SPECIES
Dogs and cats.
DOSAGE FORM
Flavoured, double-scored tablets.
HOW SUPPLIED
Box containing 30 tablets.
Hepatoprotective agent.

Silihepatic is a hepatoprotective agent with a modern, effective combination of active ingredients that helps restore liver function. It contains silybin (the main bioactive component of silymarin), which exerts an antioxidant action by scavenging free radicals. It also protects hepatocytes against inflammation and cytotoxicity, and supports liver detoxification mechanisms by increasing glutathione levels.

Contains silybin, with bioavailability up to 10 times higher than silymarin.
Inhibits oxidative damage.
Flavoured tablets.

Inhibits oxidative damage.

Contains silybin, with bioavailability up to 10 times higher than silymarin.

• Promueve el metabolismo de las grasas.
• Reduce los niveles de lípidos en sangre y en el hígado.

Inhibits oxidative damage.

• Estimula la síntesis de proteínas en el hígado.
• Comprimidos saborizados.

Flavoured tablets.

TECHNICAL DETAILS

Information

– Silybin phospholipid complex* 70 mg; SAMe (S-Adenosyl-L-Methionine disulfate tosylate) 50 mg.
– DL-Methionine 150 mg; L(+)-Choline bitartrate 10 mg.
– Vitamin E acetate 5 mg.
– Excipients q.s. to 1000 mg.
*Equivalent to 21 mg of silybin per tablet.
The flavoured tablets are administered orally, preferably on an empty stomach and at least 1 hour before feeding.
Dogs: 1 tablet per 10 kg/day (recommended dose).
Cats: 2-5 kg: ¼ tablet/day. 5 kg or more: ½ tablet/day.
The dose may be adjusted for individual cases if necessary, at the discretion of the attending veterinarian. Note that an excessive increase in the amount of methionine administered may result in urinary acidification. Treatment duration should be at least 10 days. For prolonged use, the amount administered may be reduced by half as a maintenance dose.
Scroll to Top